CUSIP: 34633R104
Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
36,991,190
-
Share change
-
+9,290,060
-
Total reported value
-
$1,290,074,367
-
Price per share
-
$34.90
-
Number of holders
-
92
-
Value change
-
+$324,326,734
-
Number of buys
-
71
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 34633R104?
CUSIP 34633R104 identifies FMTX - FORMA THERAPEUTICS HLDGS INC - SHS in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2021
-
Previous quarter:
Q3 2020
Recent filing periods for CUSIP 34633R104:
Institutional Holders of FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) as of Q4 2020
As of 31 Dec 2020,
FORMA THERAPEUTICS HLDGS INC - SHS (FMTX) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,991,190 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Cormorant Asset Management, LP, FMR LLC, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, Samsara BioCapital, LLC, Logos Global Management LP, and PERCEPTIVE ADVISORS LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.